Philippines Wound Care Market by Product (Advanced Wound Care, Surgical Wound Care, and Traditional/Basic Wound Care), Application (Chronic Wounds and Acute Wounds), and End User (Hospitals and Community Health Service Centers): Opportunity Analysis and Industry Forecast, 2018 - 2025
The Philippines wound care market size was valued at $51 million in 2017, and is projected to reach $85 million by 2025, registering a CAGR of 6.5% during the forecast period.
Traditional wound care and advanced wound care products are used in the treatment of acute and chronic wounds. Advanced wound care has emerged as a standard solution for the treatment of chronic wounds, which need substantial time to heal and incur high cost. Traditional wound care products are being increasingly substituted with advanced wound care products due to their efficiency and effectiveness to treat wounds by enabling faster healing. Increase in the number of surgical procedures and spiraling demand for technologically advanced surgical procedures such as minimally invasive surgeries and laparoscopic surgeries drive the growth of the market.
The growth of the market is attributed to the rapid growth in geriatric population & favorable demographics; rise in incidence of diabetes, obesity, and chronic conditions; technological advancements to deal with complex wounds; and increase in awareness to reduce healthcare costs. However, reluctance in adoption of new technologies restrain the growth of the market. Increased focus toward advanced treatment protocols and significant unmet needs in wound care act as growth opportunities for the market.
The Philippines wound care market is segmented based on product type, application, and end user. By product type, the market is categorized into advanced wound care, surgical wound care, and traditional/basic wound care. Advanced wound care is sub-segmented into infection management, exudate management, active wound care, and therapy devices. Infection management is the leading segment in the global market. It is further classified into silver dressings, non-silver dressings, and collagens. Exudate management is sub divided into hydrocolloid dressings, foam dressings, alginate dressings, and hydrogel dressings. Active wound care is further divided into skin substitutes and growth factors. Therapy devices is sub segmented into negative pressure wound therapy (NPWT), oxygen & hyperbaric oxygen equipment, electromagnetic therapy devices, and others. Surgical wound is further categorized into sutures & staples, tissue adhesives, sealants, & glues, and anti-infective dressings. Tissue adhesives, sealants, & glues are further divided into fibrin-based sealants, collagen-based sealants, and synthetic adhesives/glues. Traditional/basic wound care are sub segmented into medical tapes, dressings, and cleansing agents. Based on application, the market is bifurcated into chronic wound care and acute wound care. The end users of the market are hospitals and community centers.
KEY BENEFITS FOR STAKEHOLDERS
By Product
Traditional wound care and advanced wound care products are used in the treatment of acute and chronic wounds. Advanced wound care has emerged as a standard solution for the treatment of chronic wounds, which need substantial time to heal and incur high cost. Traditional wound care products are being increasingly substituted with advanced wound care products due to their efficiency and effectiveness to treat wounds by enabling faster healing. Increase in the number of surgical procedures and spiraling demand for technologically advanced surgical procedures such as minimally invasive surgeries and laparoscopic surgeries drive the growth of the market.
The growth of the market is attributed to the rapid growth in geriatric population & favorable demographics; rise in incidence of diabetes, obesity, and chronic conditions; technological advancements to deal with complex wounds; and increase in awareness to reduce healthcare costs. However, reluctance in adoption of new technologies restrain the growth of the market. Increased focus toward advanced treatment protocols and significant unmet needs in wound care act as growth opportunities for the market.
The Philippines wound care market is segmented based on product type, application, and end user. By product type, the market is categorized into advanced wound care, surgical wound care, and traditional/basic wound care. Advanced wound care is sub-segmented into infection management, exudate management, active wound care, and therapy devices. Infection management is the leading segment in the global market. It is further classified into silver dressings, non-silver dressings, and collagens. Exudate management is sub divided into hydrocolloid dressings, foam dressings, alginate dressings, and hydrogel dressings. Active wound care is further divided into skin substitutes and growth factors. Therapy devices is sub segmented into negative pressure wound therapy (NPWT), oxygen & hyperbaric oxygen equipment, electromagnetic therapy devices, and others. Surgical wound is further categorized into sutures & staples, tissue adhesives, sealants, & glues, and anti-infective dressings. Tissue adhesives, sealants, & glues are further divided into fibrin-based sealants, collagen-based sealants, and synthetic adhesives/glues. Traditional/basic wound care are sub segmented into medical tapes, dressings, and cleansing agents. Based on application, the market is bifurcated into chronic wound care and acute wound care. The end users of the market are hospitals and community centers.
KEY BENEFITS FOR STAKEHOLDERS
- The report provides an in-depth analysis of the market and the estimated revenues generated during the forecast period.
- Quantitative analysis of the current trends and future estimations is provided to help the manufacturers of wound care products to analyze the market.
- The entire projections in the report are based on analysis of the current market trends and highlight the market potential for the period from 2018 to 2025, in terms of value.
- The report conducts extensive analysis of the industry by closely following key product positioning and monitoring the top contenders within the market framework.
- The report provides quantitative and qualitative market trends to assist stakeholders to understand the situations prevailing in the market.
By Product
- Advanced Wound Care
- Infection Management
- Silver Wound Dressings
- Non-silver Wound Dressings
- Collagen Dressings
- Exudate Management
- Hydrocolloid Dressings
- Foam Dressings
- Alginate Dressings
- Hydrogel Dressings
- Active Wound Care
- Skin Substitutes
- Growth Factors
- Therapy Devices
- Negative Pressure Wound Therapy (NPWT)
- Oxygen & Hyperbaric Oxygen Equipment
- Electromagnetic Therapy Devices
- Others
- Surgical Wound Care
- Sutures & Staples
- Tissue Adhesives, Sealants, & Glues
- Fibrin-Based Sealants
- Collagen-Based Sealants
- Synthetic Adhesives/Glues
- Anti-Infective Dressings
- Traditional/Basic Wound Care
- Medical Tapes
- Dressings
- Cleansing Agents
- Chronic Wounds
- Pressure Ulcers
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Arterial Ulcers
- Acute Wounds
- Burns & Trauma
- Surgical Wounds
- Hospitals
- Community Health Service Centers
- 3M Company
- Smith & Nephew Plc.
- Coloplast A/S
- Medtronic Plc
- ConvaTec Group Plc
- Cardinal Health, Inc.
- BSN Medical GmbH
- Mundipharma International Ltd.
- B. Braun Melsungen AG
- Urgo Medical
CHAPTER: 1: INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER: 2: EXECUTIVE SUMMARY
2.1. KEY FINDINGS
2.2. CXO PERSPECTIVE
CHAPTER: 3: MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.3. PORTER’S FIVE FORCES ANALYSIS
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry
3.4. TOP PLAYER POSITIONING, 2017
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Rise in geriatric population and favorable demographics
3.5.1.2. Growth in incidence of diabetes, obesity, and chronic conditions
3.5.1.3. Technological advancements to deal with complex wounds
3.5.1.4. Increase in awareness to reduce healthcare costs
3.5.2. Restraints
3.5.2.1. Reluctance in adoption of new technologies
3.5.2.2. Development of substitute products and lack of sufficient evidence
3.5.3. Opportunities
3.5.3.1. Increase in focus towards advanced treatment protocols
3.6. REGULATORY ANALYSIS
3.6.1. Regulatory approval for medical products in the Philippines
3.6.1.1. License To Operate (LTO):
3.6.1.2. Product Registration:
3.6.1.2.1. General Guidelines
3.6.1.2.2. Specific Guidelines
3.6.1.2.3. Legal Requirements for Application for the Notification of Medical Devices under Class A and Registration of Medical Devices under Classes B, C and D
3.7. CLINICAL TRIALS FOR WOUND CARE PRODUCTS
CHAPTER: 4: PHILIPPINES WOUND CARE MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. ADVANCED WOUND CARE
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.2.1. Infection management
4.2.2.1.1. Market size and forecast
4.2.2.1.1.1. Silver wound dressings
4.2.2.1.1.1.1.Market size and forecast
4.2.2.1.1.2. Non-silver dressings
4.2.2.1.1.2.1.Market size and forecast
4.2.2.1.1.3. Collagen dressings
4.2.2.1.1.3.1.Market size and forecast
4.2.2.2. Exudate management
4.2.2.2.1. Market size and forecast
4.2.2.2.1.1. Hydrocolloid dressings
4.2.2.2.1.1.1.Market size and forecast
4.2.2.2.1.2. Foam dressings
4.2.2.2.1.2.1.Market size and forecast
4.2.2.2.1.3. Alginate dressings
4.2.2.2.1.3.1.Market size and forecast
4.2.2.2.1.4. Hydrogel dressings
4.2.2.2.1.4.1.Market size and forecast
4.2.2.3. Active wound care
4.2.2.3.1. Market size and forecast
4.2.2.3.1.1. Skin substitutes
4.2.2.3.1.1.1.Market size and forecast
4.2.2.3.1.2. Growth factors
4.2.2.3.1.2.1.Market size and forecast
4.2.2.4. Therapy device
4.2.2.4.1. Market size and forecast
4.2.2.4.1.1. Negative pressure wound therapy (NPWT)
4.2.2.4.1.1.1.Market size and forecast
4.2.2.4.1.2. Oxygen & hyperbaric oxygen equipment
4.2.2.4.1.2.1.Market size and forecast
4.2.2.4.1.3. Electromagnetic therapy devices
4.2.2.4.1.3.1.Market size and forecast
4.2.2.4.1.4. Others
4.2.2.4.1.4.1.Market size and forecast
4.3. SURGICAL WOUND CARE
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.3.2.1. Sutures & staples
4.3.2.1.1. Market size and forecast
4.3.2.2. Tissue adhesives, sealants, & glues
4.3.2.2.1. Market size and forecast
4.3.2.2.1.1. Fibrin-based sealants
4.3.2.2.1.1.1.Market size and forecast
4.3.2.2.1.2. Collagen-based sealants
4.3.2.2.1.2.1.Market size and forecast
4.3.2.2.1.3. Synthetic adhesives/glues
4.3.2.2.1.3.1.Market size and forecast
4.3.2.3. Anti-infective dressing
4.3.2.3.1. Market size and forecast
4.4. TRADITIONAL/BASIC WOUND CARE
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.2.1. Medical tapes
4.4.2.1.1. Market size and forecast
4.4.2.2. Dressings
4.4.2.2.1. Market size and forecast
4.4.2.3. Cleansing agents
4.4.2.3.1. Market size and forecast
CHAPTER: 5: PHILIPPINES WOUND CARE MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. CHRONIC WOUNDS
5.2.1. Market size and forecast
5.2.1.1. Pressure ulcers
5.2.1.1.1. Market size and forecast
5.2.1.2. Diabetic foot ulcers
5.2.1.2.1. Market size and forecast
5.2.1.3. Venous leg ulcers
5.2.1.3.1. Market size and forecast
5.2.1.4. Arterial ulcers
5.2.1.4.1. Market size and forecast
5.3. ACUTE WOUNDS
5.3.1. Market size and forecast
5.3.1.1. Burns & trauma
5.3.1.1.1. Market size and forecast
5.3.1.2. Surgical wounds
5.3.1.2.1. Market size and forecast
CHAPTER: 6: PHILIPPINES WOUND CARE MARKET, BY END USER
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. HOSPITALS
6.2.1. Market size and forecast
6.3. COMMUNITY HEALTH SERVICE CENTERS
6.3.1. Market size and forecast
CHAPTER: 7: COMPANY PROFILES
7.1. 3M COMPANY
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. B. BRAUN MELSUNGEN AG
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. CARDINAL HEALTH, INC.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.4. COLOPLAST A/S
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. CONVATEC GROUP PLC
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.6. MEDTRONIC PLC. (COVIDIEN LTD.)
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. MUNDIPHARMA INTERNATIONAL LIMITED
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.8. SMITH & NEPHEW PLC.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.9. SVENSKA CELLULOSA AKTIEBOLAGET (BSN MEDICAL GMBH)
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Product portfolio
7.9.4. Business performance
7.10. URGO GROUP (URGO MEDICAL)
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER: 2: EXECUTIVE SUMMARY
2.1. KEY FINDINGS
2.2. CXO PERSPECTIVE
CHAPTER: 3: MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.3. PORTER’S FIVE FORCES ANALYSIS
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry
3.4. TOP PLAYER POSITIONING, 2017
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Rise in geriatric population and favorable demographics
3.5.1.2. Growth in incidence of diabetes, obesity, and chronic conditions
3.5.1.3. Technological advancements to deal with complex wounds
3.5.1.4. Increase in awareness to reduce healthcare costs
3.5.2. Restraints
3.5.2.1. Reluctance in adoption of new technologies
3.5.2.2. Development of substitute products and lack of sufficient evidence
3.5.3. Opportunities
3.5.3.1. Increase in focus towards advanced treatment protocols
3.6. REGULATORY ANALYSIS
3.6.1. Regulatory approval for medical products in the Philippines
3.6.1.1. License To Operate (LTO):
3.6.1.2. Product Registration:
3.6.1.2.1. General Guidelines
3.6.1.2.2. Specific Guidelines
3.6.1.2.3. Legal Requirements for Application for the Notification of Medical Devices under Class A and Registration of Medical Devices under Classes B, C and D
3.7. CLINICAL TRIALS FOR WOUND CARE PRODUCTS
CHAPTER: 4: PHILIPPINES WOUND CARE MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. ADVANCED WOUND CARE
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.2.1. Infection management
4.2.2.1.1. Market size and forecast
4.2.2.1.1.1. Silver wound dressings
4.2.2.1.1.1.1.Market size and forecast
4.2.2.1.1.2. Non-silver dressings
4.2.2.1.1.2.1.Market size and forecast
4.2.2.1.1.3. Collagen dressings
4.2.2.1.1.3.1.Market size and forecast
4.2.2.2. Exudate management
4.2.2.2.1. Market size and forecast
4.2.2.2.1.1. Hydrocolloid dressings
4.2.2.2.1.1.1.Market size and forecast
4.2.2.2.1.2. Foam dressings
4.2.2.2.1.2.1.Market size and forecast
4.2.2.2.1.3. Alginate dressings
4.2.2.2.1.3.1.Market size and forecast
4.2.2.2.1.4. Hydrogel dressings
4.2.2.2.1.4.1.Market size and forecast
4.2.2.3. Active wound care
4.2.2.3.1. Market size and forecast
4.2.2.3.1.1. Skin substitutes
4.2.2.3.1.1.1.Market size and forecast
4.2.2.3.1.2. Growth factors
4.2.2.3.1.2.1.Market size and forecast
4.2.2.4. Therapy device
4.2.2.4.1. Market size and forecast
4.2.2.4.1.1. Negative pressure wound therapy (NPWT)
4.2.2.4.1.1.1.Market size and forecast
4.2.2.4.1.2. Oxygen & hyperbaric oxygen equipment
4.2.2.4.1.2.1.Market size and forecast
4.2.2.4.1.3. Electromagnetic therapy devices
4.2.2.4.1.3.1.Market size and forecast
4.2.2.4.1.4. Others
4.2.2.4.1.4.1.Market size and forecast
4.3. SURGICAL WOUND CARE
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.3.2.1. Sutures & staples
4.3.2.1.1. Market size and forecast
4.3.2.2. Tissue adhesives, sealants, & glues
4.3.2.2.1. Market size and forecast
4.3.2.2.1.1. Fibrin-based sealants
4.3.2.2.1.1.1.Market size and forecast
4.3.2.2.1.2. Collagen-based sealants
4.3.2.2.1.2.1.Market size and forecast
4.3.2.2.1.3. Synthetic adhesives/glues
4.3.2.2.1.3.1.Market size and forecast
4.3.2.3. Anti-infective dressing
4.3.2.3.1. Market size and forecast
4.4. TRADITIONAL/BASIC WOUND CARE
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.2.1. Medical tapes
4.4.2.1.1. Market size and forecast
4.4.2.2. Dressings
4.4.2.2.1. Market size and forecast
4.4.2.3. Cleansing agents
4.4.2.3.1. Market size and forecast
CHAPTER: 5: PHILIPPINES WOUND CARE MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. CHRONIC WOUNDS
5.2.1. Market size and forecast
5.2.1.1. Pressure ulcers
5.2.1.1.1. Market size and forecast
5.2.1.2. Diabetic foot ulcers
5.2.1.2.1. Market size and forecast
5.2.1.3. Venous leg ulcers
5.2.1.3.1. Market size and forecast
5.2.1.4. Arterial ulcers
5.2.1.4.1. Market size and forecast
5.3. ACUTE WOUNDS
5.3.1. Market size and forecast
5.3.1.1. Burns & trauma
5.3.1.1.1. Market size and forecast
5.3.1.2. Surgical wounds
5.3.1.2.1. Market size and forecast
CHAPTER: 6: PHILIPPINES WOUND CARE MARKET, BY END USER
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. HOSPITALS
6.2.1. Market size and forecast
6.3. COMMUNITY HEALTH SERVICE CENTERS
6.3.1. Market size and forecast
CHAPTER: 7: COMPANY PROFILES
7.1. 3M COMPANY
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. B. BRAUN MELSUNGEN AG
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. CARDINAL HEALTH, INC.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.4. COLOPLAST A/S
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. CONVATEC GROUP PLC
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.6. MEDTRONIC PLC. (COVIDIEN LTD.)
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. MUNDIPHARMA INTERNATIONAL LIMITED
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.8. SMITH & NEPHEW PLC.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.9. SVENSKA CELLULOSA AKTIEBOLAGET (BSN MEDICAL GMBH)
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Product portfolio
7.9.4. Business performance
7.10. URGO GROUP (URGO MEDICAL)
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
LIST OF TABLES
TABLE 01. PHILIPPINES WOUND CARE: MARKET SEGMENTATION
TABLE 02. MEDICAL DEVICE CLASSIFICATION IN THE PHILIPPINES
TABLE 03. CLINICAL TRIALS FOR WOUND CARE
TABLE 04. PHILIPPINES WOUND CARE MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 05. PHILIPPINES ADVANCED WOUND CARE MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 06. PHILIPPINES ADVANCED WOUND CARE MARKET FOR INFECTION MANAGEMENT, BY TYPE, 2017-2025 ($MILLION)
TABLE 07. PHILIPPINES ADVANCED WOUND CARE MARKET FOR EXUDATE MANAGEMENT, BY TYPE, 2017-2025 ($MILLION)
TABLE 08. PHILIPPINES ADVANCED WOUND CARE MARKET FOR ACTIVE WOUND CARE, BY TYPE, 2017-2025 ($MILLION)
TABLE 09. PHILIPPINES ADVANCED WOUND CARE MARKET FOR THERAPY DEVICES, BY TYPE, 2017-2025 ($MILLION)
TABLE 10. PHILIPPINES SURGICAL WOUND CARE MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 11. PHILIPPINES SURGICAL WOUND CARE MARKET FOR TISSUE ADHESIVES, SEALANTS, & GLUES, BY TYPE, 2017-2025 ($MILLION)
TABLE 12. PHILIPPINES TRADITIONAL WOUND CARE MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 13. PHILIPPINES CHRONIC WOUND CARE MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 14. PHILIPPINES ACUTE WOUND CARE MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 15. PHILIPPINES WOUND CARE MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 16. 3M: COMPANY SNAPSHOT
TABLE 17. 3M: OPERATING SEGMENTS
TABLE 18. 3M: PRODUCT PORTFOLIO
TABLE 19. B. BRAUN: COMPANY SNAPSHOT
TABLE 20. B. BRAUN: OPERATING SEGMENTS
TABLE 21. B. BRAUN: PRODUCT PORTFOLIO
TABLE 22. CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 23. CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 24. CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 25. COLOPLAST: COMPANY SNAPSHOT
TABLE 26. COLOPLAST: OPERATING SEGMENTS
TABLE 27. COLOPLAST: PRODUCT PORTFOLIO
TABLE 28. CONVATEC: COMPANY SNAPSHOT
TABLE 29. CONVATEC: OPERATING SEGMENTS
TABLE 30. CONVATEC: PRODUCT PORTFOLIO
TABLE 31. MEDTRONIC: COMPANY SNAPSHOT
TABLE 32. MEDTRONIC: OPERATING SEGMENTS
TABLE 33. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 34. MUNDIPHARAMA: COMPANY SNAPSHOT
TABLE 35. MUNDIPHARAMA: PRODUCT SEGMENTS
TABLE 36. MUNDIPHARAMA: PRODUCT PORTFOLIO
TABLE 37. SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 38. SMITH & NEPHEW: PRODUCT SEGMENTS
TABLE 39. SMITH & NEPHEW: PRODUCT PORTFOLIO
TABLE 40. SCA: COMPANY SNAPSHOT
TABLE 41. BSN MEDICAL: PRODUCT PORTFOLIO
TABLE 42. URGO MEDICAL: COMPANY SNAPSHOT
TABLE 43. URGO MEDICAL: BUSINESS SEGMENTS
TABLE 44. URGO MEDICAL: PRODUCT PORTFOLIO
TABLE 01. PHILIPPINES WOUND CARE: MARKET SEGMENTATION
TABLE 02. MEDICAL DEVICE CLASSIFICATION IN THE PHILIPPINES
TABLE 03. CLINICAL TRIALS FOR WOUND CARE
TABLE 04. PHILIPPINES WOUND CARE MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 05. PHILIPPINES ADVANCED WOUND CARE MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 06. PHILIPPINES ADVANCED WOUND CARE MARKET FOR INFECTION MANAGEMENT, BY TYPE, 2017-2025 ($MILLION)
TABLE 07. PHILIPPINES ADVANCED WOUND CARE MARKET FOR EXUDATE MANAGEMENT, BY TYPE, 2017-2025 ($MILLION)
TABLE 08. PHILIPPINES ADVANCED WOUND CARE MARKET FOR ACTIVE WOUND CARE, BY TYPE, 2017-2025 ($MILLION)
TABLE 09. PHILIPPINES ADVANCED WOUND CARE MARKET FOR THERAPY DEVICES, BY TYPE, 2017-2025 ($MILLION)
TABLE 10. PHILIPPINES SURGICAL WOUND CARE MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 11. PHILIPPINES SURGICAL WOUND CARE MARKET FOR TISSUE ADHESIVES, SEALANTS, & GLUES, BY TYPE, 2017-2025 ($MILLION)
TABLE 12. PHILIPPINES TRADITIONAL WOUND CARE MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 13. PHILIPPINES CHRONIC WOUND CARE MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 14. PHILIPPINES ACUTE WOUND CARE MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 15. PHILIPPINES WOUND CARE MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 16. 3M: COMPANY SNAPSHOT
TABLE 17. 3M: OPERATING SEGMENTS
TABLE 18. 3M: PRODUCT PORTFOLIO
TABLE 19. B. BRAUN: COMPANY SNAPSHOT
TABLE 20. B. BRAUN: OPERATING SEGMENTS
TABLE 21. B. BRAUN: PRODUCT PORTFOLIO
TABLE 22. CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 23. CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 24. CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 25. COLOPLAST: COMPANY SNAPSHOT
TABLE 26. COLOPLAST: OPERATING SEGMENTS
TABLE 27. COLOPLAST: PRODUCT PORTFOLIO
TABLE 28. CONVATEC: COMPANY SNAPSHOT
TABLE 29. CONVATEC: OPERATING SEGMENTS
TABLE 30. CONVATEC: PRODUCT PORTFOLIO
TABLE 31. MEDTRONIC: COMPANY SNAPSHOT
TABLE 32. MEDTRONIC: OPERATING SEGMENTS
TABLE 33. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 34. MUNDIPHARAMA: COMPANY SNAPSHOT
TABLE 35. MUNDIPHARAMA: PRODUCT SEGMENTS
TABLE 36. MUNDIPHARAMA: PRODUCT PORTFOLIO
TABLE 37. SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 38. SMITH & NEPHEW: PRODUCT SEGMENTS
TABLE 39. SMITH & NEPHEW: PRODUCT PORTFOLIO
TABLE 40. SCA: COMPANY SNAPSHOT
TABLE 41. BSN MEDICAL: PRODUCT PORTFOLIO
TABLE 42. URGO MEDICAL: COMPANY SNAPSHOT
TABLE 43. URGO MEDICAL: BUSINESS SEGMENTS
TABLE 44. URGO MEDICAL: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. TOP INVESTMENT POCKETS IN PHILIPPINES WOUND CARE MARKET
FIGURE 02. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 03. MODERATE BARGAINING POWER OF BUYERS
FIGURE 04. LOW THREAT OF SUBSTITUTES
FIGURE 05. MODERATE THREAT OF NEW ENTRANTS
FIGURE 06. HIGH COMPETITIVE RIVALRY
FIGURE 07. PHILIPPINES WOUND CARE MARKET, TOP PLAYER POSITIONING, 2017
FIGURE 08. PHILIPPINES SILVER WOUND DRESSINGS MARKET, 2017–2025 ($MILLION)
FIGURE 09. PHILIPPINES NON-SILVER WOUND DRESSINGS MARKET, 2017–2025 ($MILLION)
FIGURE 10. PHILIPPINES COLLAGEN WOUND DRESSINGS MARKET, 2017–2025 ($MILLION)
FIGURE 11. PHILIPPINES HYDROCOLLOID DRESSINGS MARKET, 2017–2025 ($MILLION)
FIGURE 12. PHILIPPINES FOAM DRESSINGS MARKET, 2017–2025 ($MILLION)
FIGURE 13. PHILIPPINES ALGINATE DRESSINGS MARKET, 2017–2025 ($MILLION)
FIGURE 14. PHILIPPINES HYDROGEL DRESSINGS MARKET, 2017–2025 ($MILLION)
FIGURE 15. PHILIPPINES SKIN SUBSTITUTES MARKET, 2017–2025 ($MILLION)
FIGURE 16. PHILIPPINES GROWTH FACTORS MARKET, 2017–2025 ($MILLION)
FIGURE 17. PHILIPPINES NEGATIVE PRESSURE WOUND THERAPY MARKET, 2017–2025 ($MILLION)
FIGURE 18. PHILIPPINES OXYGEN & HYPERBARIC OXYGEN EQUIPMENT MARKET, 2017–2025 ($MILLION)
FIGURE 19. PHILIPPINES ELECTROMAGNETIC THERAPY DEVICES MARKET, 2017–2025 ($MILLION)
FIGURE 20. PHILIPPINES OTHER THERAPY DEVICES MARKET, 2017–2025 ($MILLION)
FIGURE 21. PHILIPPINES SURGICAL WOUND CARE MARKET FOR SUTURES & STAPLES, 2017-2025 ($MILLION)
FIGURE 22. PHILIPPINES FIBRIN-BASED SEALANTS MARKET, 2017–2025 ($MILLION)
FIGURE 23. PHILIPPINES COLLAGEN-BASED SEALANTS MARKET, 2017–2025 ($MILLION)
FIGURE 24. PHILIPPINES SYNTHETIC ADHESIVES MARKET, 2017–2025 ($MILLION)
FIGURE 25. PHILIPPINES ANTI-INFECTIVE DRESSINGS MARKET, 2017-2025 ($MILLION)
FIGURE 26. PHILIPPINES TRADITIONAL WOUND CARE MARKET FOR MEDICAL TAPES, 2017-2025 ($MILLION)
FIGURE 27. PHILIPPINES TRADITIONAL WOUND CARE MARKET FOR DRESSINGS, 2017-2025 ($MILLION)
FIGURE 28. PHILIPPINES TRADITIONAL WOUND CARE MARKET FOR CLEANSINGS AGENTS, 2017-2025 ($MILLION)
FIGURE 29. PHILIPPINES WOUND CARE MARKET, BY APPLICATION, 2017-2025 ($MILLION)
FIGURE 30. PHILIPPINES CHRONIC WOUND CARE MARKET FOR PRESSURE ULCERS, 2017-2025 ($MILLION)
FIGURE 31. PHILIPPINES CHRONIC WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, 2017-2025 ($MILLION)
FIGURE 32. PHILIPPINES CHRONIC WOUND CARE MARKET FOR VENOUS LEG ULCERS, 2017-2025 ($MILLION)
FIGURE 33. PHILIPPINES CHRONIC WOUND CARE MARKET FOR ARTERIAL ULCERS, 2017-2025 ($MILLION)
FIGURE 34. PHILIPPINES ACUTE WOUND CARE MARKET FOR BURNS & TRAUMA, 2017-2025 ($MILLION)
FIGURE 35. PHILIPPINES ACUTE WOUND CARE MARKET FOR SURGICAL WOUNDS, 2017-2025 ($MILLION)
FIGURE 36. PHILIPPINES WOUND CARE MARKET FOR HOSPITALS, 2017–2025 ($MILLION)
FIGURE 37. PHILIPPINES WOUND CARE MARKET FOR COMMUNITY HEALTH SERVICE CENTERS, 2017–2025 ($MILLION)
FIGURE 38. 3M: NET SALES, 2015–2017 ($MILLION)
FIGURE 39. 3M: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 40. 3M: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 41. B. BRAUN: NET SALES, 2015–2017 ($MILLION)
FIGURE 42. B. BRAUN: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 43. B. BRAUN: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 44. CARDINAL HEALTH: NET SALES, 2015–2017 ($MILLION)
FIGURE 45. CARDINAL HEALTH: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 46. CARDINAL HEALTH: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 47. COLOPLAST: NET SALES, 2015–2017 ($MILLION)
FIGURE 48. COLOPLAST: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 49. COLOPLAST: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 50. CONVATEC: NET SALES, 2015–2017 ($MILLION)
FIGURE 51. CONVATEC: REVENUE SHARE BY PRODUCT, 2017 (%)
FIGURE 52. CONVATEC: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 53. MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 54. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 55. MEDTRONIC: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 56. SMITH & NEPHEW: NET SALES, 2015–2017 ($MILLION)
FIGURE 57. SMITH & NEPHEW: REVENUE SHARE BY PRODUCT, 2017 (%)
FIGURE 58. SMITH & NEPHEW: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 59. SCA: NET SALES, 2015–2017 ($MILLION)
FIGURE 60. SCA: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 61. SCA: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 01. TOP INVESTMENT POCKETS IN PHILIPPINES WOUND CARE MARKET
FIGURE 02. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 03. MODERATE BARGAINING POWER OF BUYERS
FIGURE 04. LOW THREAT OF SUBSTITUTES
FIGURE 05. MODERATE THREAT OF NEW ENTRANTS
FIGURE 06. HIGH COMPETITIVE RIVALRY
FIGURE 07. PHILIPPINES WOUND CARE MARKET, TOP PLAYER POSITIONING, 2017
FIGURE 08. PHILIPPINES SILVER WOUND DRESSINGS MARKET, 2017–2025 ($MILLION)
FIGURE 09. PHILIPPINES NON-SILVER WOUND DRESSINGS MARKET, 2017–2025 ($MILLION)
FIGURE 10. PHILIPPINES COLLAGEN WOUND DRESSINGS MARKET, 2017–2025 ($MILLION)
FIGURE 11. PHILIPPINES HYDROCOLLOID DRESSINGS MARKET, 2017–2025 ($MILLION)
FIGURE 12. PHILIPPINES FOAM DRESSINGS MARKET, 2017–2025 ($MILLION)
FIGURE 13. PHILIPPINES ALGINATE DRESSINGS MARKET, 2017–2025 ($MILLION)
FIGURE 14. PHILIPPINES HYDROGEL DRESSINGS MARKET, 2017–2025 ($MILLION)
FIGURE 15. PHILIPPINES SKIN SUBSTITUTES MARKET, 2017–2025 ($MILLION)
FIGURE 16. PHILIPPINES GROWTH FACTORS MARKET, 2017–2025 ($MILLION)
FIGURE 17. PHILIPPINES NEGATIVE PRESSURE WOUND THERAPY MARKET, 2017–2025 ($MILLION)
FIGURE 18. PHILIPPINES OXYGEN & HYPERBARIC OXYGEN EQUIPMENT MARKET, 2017–2025 ($MILLION)
FIGURE 19. PHILIPPINES ELECTROMAGNETIC THERAPY DEVICES MARKET, 2017–2025 ($MILLION)
FIGURE 20. PHILIPPINES OTHER THERAPY DEVICES MARKET, 2017–2025 ($MILLION)
FIGURE 21. PHILIPPINES SURGICAL WOUND CARE MARKET FOR SUTURES & STAPLES, 2017-2025 ($MILLION)
FIGURE 22. PHILIPPINES FIBRIN-BASED SEALANTS MARKET, 2017–2025 ($MILLION)
FIGURE 23. PHILIPPINES COLLAGEN-BASED SEALANTS MARKET, 2017–2025 ($MILLION)
FIGURE 24. PHILIPPINES SYNTHETIC ADHESIVES MARKET, 2017–2025 ($MILLION)
FIGURE 25. PHILIPPINES ANTI-INFECTIVE DRESSINGS MARKET, 2017-2025 ($MILLION)
FIGURE 26. PHILIPPINES TRADITIONAL WOUND CARE MARKET FOR MEDICAL TAPES, 2017-2025 ($MILLION)
FIGURE 27. PHILIPPINES TRADITIONAL WOUND CARE MARKET FOR DRESSINGS, 2017-2025 ($MILLION)
FIGURE 28. PHILIPPINES TRADITIONAL WOUND CARE MARKET FOR CLEANSINGS AGENTS, 2017-2025 ($MILLION)
FIGURE 29. PHILIPPINES WOUND CARE MARKET, BY APPLICATION, 2017-2025 ($MILLION)
FIGURE 30. PHILIPPINES CHRONIC WOUND CARE MARKET FOR PRESSURE ULCERS, 2017-2025 ($MILLION)
FIGURE 31. PHILIPPINES CHRONIC WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, 2017-2025 ($MILLION)
FIGURE 32. PHILIPPINES CHRONIC WOUND CARE MARKET FOR VENOUS LEG ULCERS, 2017-2025 ($MILLION)
FIGURE 33. PHILIPPINES CHRONIC WOUND CARE MARKET FOR ARTERIAL ULCERS, 2017-2025 ($MILLION)
FIGURE 34. PHILIPPINES ACUTE WOUND CARE MARKET FOR BURNS & TRAUMA, 2017-2025 ($MILLION)
FIGURE 35. PHILIPPINES ACUTE WOUND CARE MARKET FOR SURGICAL WOUNDS, 2017-2025 ($MILLION)
FIGURE 36. PHILIPPINES WOUND CARE MARKET FOR HOSPITALS, 2017–2025 ($MILLION)
FIGURE 37. PHILIPPINES WOUND CARE MARKET FOR COMMUNITY HEALTH SERVICE CENTERS, 2017–2025 ($MILLION)
FIGURE 38. 3M: NET SALES, 2015–2017 ($MILLION)
FIGURE 39. 3M: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 40. 3M: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 41. B. BRAUN: NET SALES, 2015–2017 ($MILLION)
FIGURE 42. B. BRAUN: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 43. B. BRAUN: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 44. CARDINAL HEALTH: NET SALES, 2015–2017 ($MILLION)
FIGURE 45. CARDINAL HEALTH: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 46. CARDINAL HEALTH: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 47. COLOPLAST: NET SALES, 2015–2017 ($MILLION)
FIGURE 48. COLOPLAST: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 49. COLOPLAST: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 50. CONVATEC: NET SALES, 2015–2017 ($MILLION)
FIGURE 51. CONVATEC: REVENUE SHARE BY PRODUCT, 2017 (%)
FIGURE 52. CONVATEC: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 53. MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 54. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 55. MEDTRONIC: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 56. SMITH & NEPHEW: NET SALES, 2015–2017 ($MILLION)
FIGURE 57. SMITH & NEPHEW: REVENUE SHARE BY PRODUCT, 2017 (%)
FIGURE 58. SMITH & NEPHEW: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 59. SCA: NET SALES, 2015–2017 ($MILLION)
FIGURE 60. SCA: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 61. SCA: REVENUE SHARE BY REGION, 2017 (%)
